Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MasterCard Inc (MA) vs Medtronic PLC (MDT) Price & Performance

MasterCard IncTrade
Medtronic PLCTrade

Price performance (Past 24H)

Key statistics

MasterCard Inc vs Medtronic PLC — how do they compare? MasterCard Inc trades at $559.1 (market cap $493.34B), while Medtronic PLC trades at $90.5 (market cap $114.45B). The key difference: MasterCard Inc is far larger — about 4.3× Medtronic PLC's market cap, and Medtronic PLC pays the higher dividend (3.22%). Which is the better fit depends on your goals.

MAMDT
Market Cap
$493.34B$114.45B
Volume
4,635,698
Sector
Consumer CyclicalHealth
52-Week High
$598.96$105.35
52-Week Low
$471.55$73.75
Enterprise Value
$506.38B$133.19B
Dividend Yield
0.62%3.22%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MasterCard Inc

Mastercard (MA) trades at $563.17, up 0.04% today, with a bullish technical signal and strong institutional buying. The stock shows robust fundamentals, with revenue growing from $22.2B in 2022 to $32.8B in 2025 and net income margins above 45%. Recent earnings beats and a consensus price target of $660.85 reflect optimism, though high valuation ratios like a P/E of 30.98 warrant caution.

Outlook is positive due to consistent earnings growth, expanding digital payment initiatives, and analyst buy ratings. Risks include competitive pressures from new payment technologies and regulatory scrutiny. The stock offers upside potential but requires monitoring of valuation and market shifts.

Medtronic PLC

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About MasterCard Inc

Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.

Read more on MA

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Read more on MDT